177 related articles for article (PubMed ID: 17466325)
1. Effects of atorvastatin and simvastatin on atrial plateau currents.
Vaquero M; Caballero R; Gómez R; Núñez L; Tamargo J; Delpón E
J Mol Cell Cardiol; 2007 May; 42(5):931-45. PubMed ID: 17466325
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations.
Caballero R; Gómez R; Núñez L; Moreno I; Tamargo J; Delpón E
Cardiovasc Res; 2004 Dec; 64(3):457-66. PubMed ID: 15537499
[TBL] [Abstract][Full Text] [Related]
3. Spironolactone and its main metabolite canrenoic acid block hKv1.5, Kv4.3 and Kv7.1 + minK channels.
Gómez R; Núñez L; Caballero R; Vaquero M; Tamargo J; Delpón E
Br J Pharmacol; 2005 Sep; 146(1):146-61. PubMed ID: 15980874
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (Ito1).
Gómez R; Núñez L; Vaquero M; Amorós I; Barana A; de Prada T; Macaya C; Maroto L; Rodríguez E; Caballero R; López-Farré A; Tamargo J; Delpón E
Cardiovasc Res; 2008 Dec; 80(3):375-84. PubMed ID: 18678642
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization.
Tang Q; Huang J; Qian H; Chen L; Wang T; Wang H; Shen D; Wu H; Xiong R
Life Sci; 2007 Jan; 80(7):601-8. PubMed ID: 17217967
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel Kv1.5 channel blocker in Xenopus oocytes, CHO cells, human and rat cardiomyocytes.
Bachmann A; Gutcher I; Kopp K; Brendel J; Bosch RF; Busch AE; Gögelein H
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):472-8. PubMed ID: 11692231
[TBL] [Abstract][Full Text] [Related]
7. Papaverine blocks hKv1.5 channel current and human atrial ultrarapid delayed rectifier K+ currents.
Choe H; Lee YK; Lee YT; Choe H; Ko SH; Joo CU; Kim MH; Kim GS; Eun JS; Kim JH; Chae SW; Kwak YG
J Pharmacol Exp Ther; 2003 Feb; 304(2):706-12. PubMed ID: 12538825
[TBL] [Abstract][Full Text] [Related]
8. Open channel block of A-type, kv4.3, and delayed rectifier K+ channels, Kv1.3 and Kv3.1, by sibutramine.
Kim SE; Ahn HS; Choi BH; Jang HJ; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Hahn SJ
J Pharmacol Exp Ther; 2007 May; 321(2):753-62. PubMed ID: 17312186
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism.
Núñez L; Vaquero M; Gómez R; Caballero R; Mateos-Cáceres P; Macaya C; Iriepa I; Gálvez E; López-Farré A; Tamargo J; Delpón E
Cardiovasc Res; 2006 Oct; 72(1):80-9. PubMed ID: 16876149
[TBL] [Abstract][Full Text] [Related]
10. Novel, potent inhibitors of human Kv1.5 K+ channels and ultrarapidly activating delayed rectifier potassium current.
Lagrutta A; Wang J; Fermini B; Salata JJ
J Pharmacol Exp Ther; 2006 Jun; 317(3):1054-63. PubMed ID: 16522807
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mibefradil block of the human heart delayed rectifier hKv1.5.
Perchenet L; Clément-Chomienne O
J Pharmacol Exp Ther; 2000 Nov; 295(2):771-8. PubMed ID: 11046117
[TBL] [Abstract][Full Text] [Related]
12. 2-[2-(3,4-dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD-307243) causes instantaneous current through human ether-a-go-go-related gene potassium channels.
Gordon E; Lozinskaya IM; Lin Z; Semus SF; Blaney FE; Willette RN; Xu X
Mol Pharmacol; 2008 Mar; 73(3):639-51. PubMed ID: 18042732
[TBL] [Abstract][Full Text] [Related]
13. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
[TBL] [Abstract][Full Text] [Related]
14. Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro.
Demyanets S; Kaun C; Pfaffenberger S; Hohensinner PJ; Rega G; Pammer J; Maurer G; Huber K; Wojta J
Biochem Pharmacol; 2006 Apr; 71(9):1324-30. PubMed ID: 16540096
[TBL] [Abstract][Full Text] [Related]
15. Block of cloned Kv4.3 potassium channels by dapoxetine.
Jeong I; Kim SW; Yoon SH; Hahn SJ
Neuropharmacology; 2012 Jun; 62(7):2261-6. PubMed ID: 22192593
[TBL] [Abstract][Full Text] [Related]
16. Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits.
Laszlo R; Menzel KA; Bentz K; Schreiner B; Kettering K; Eick C; Schreieck J
Life Sci; 2010 Oct; 87(15-16):507-13. PubMed ID: 20851131
[TBL] [Abstract][Full Text] [Related]
17. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells.
Tang Q; Jin MW; Xiang JZ; Dong MQ; Sun HY; Lau CP; Li GR
Biochem Pharmacol; 2007 Dec; 74(11):1596-607. PubMed ID: 17826747
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human cardiac Kv1.5 inhibition by the novel atrial-selective antiarrhythmic compound AVE1231.
Ehrlich JR; Ocholla H; Ziemek D; Rütten H; Hohnloser SH; Gögelein H
J Cardiovasc Pharmacol; 2008 Apr; 51(4):380-7. PubMed ID: 18427281
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation.
Tanaka K; Honda M; Takabatake T
Clin Exp Pharmacol Physiol; 2004; 31(5-6):360-4. PubMed ID: 15191412
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis.
Neuhaus O; Hartung HP
Expert Rev Neurother; 2007 May; 7(5):547-56. PubMed ID: 17492904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
